Cannabis May Increase Psychosis Risk Through Immune System Disruption
A systematic review of 122 studies found that external cannabinoids generally suppress immune function, potentially creating immune conditions during adolescence that increase vulnerability to psychosis.
Quick Facts
What This Study Found
The review identified a clear dichotomy: endocannabinoids (produced naturally in the body) generally enhanced immune responses, while exogenous cannabinoids (from cannabis) had immunosuppressant effects. Both types shifted the immune response from Th1 (pro-inflammatory, antiviral) to Th2 (anti-inflammatory, allergic) patterns.
Both endogenous and synthetic cannabinoids modulated microglial function and neurotransmitter secretion. The peripheral immune effects of cannabinoids were predictable and consistent, but their effects in the central nervous system remained less clear.
The authors hypothesize that exposure to external cannabinoids during adolescence could trigger immunological dysfunctions that create latent vulnerability to psychosis, providing a biological mechanism linking cannabis use to psychotic disorders.
Key Numbers
122 articles reviewed from 446 references. Key finding: exogenous cannabinoids are immunosuppressant while endocannabinoids enhance immune response. Both shift immune balance from Th1 to Th2.
How They Did This
A comprehensive search of PubMed/MEDLINE, EMBASE, and ISI Web of Knowledge was conducted using combinations of terms related to immune function, cannabinoids, and endocannabinoid receptors. 122 articles were identified from 446 references. Studies were included if they reported quantitative or qualitative relationships between cannabinoid ligands, their receptors, and the immune system in vitro or in mammals including humans.
Why This Research Matters
The link between cannabis use and psychosis is well-established epidemiologically, but the biological mechanism has been unclear. This review proposes that the immune system could be the missing link, offering a testable hypothesis for how cannabis exposure, particularly during adolescence, increases psychosis risk.
The Bigger Picture
The neuroinflammation hypothesis of psychosis has been gaining traction, with evidence that immune system alterations play a role in schizophrenia. This review connects cannabis pharmacology to immune-mediated psychosis risk, opening potential avenues for prevention and early intervention.
What This Study Doesn't Tell Us
The hypothesis linking cannabis immune effects to psychosis is largely theoretical. Most evidence comes from in vitro and animal studies. The causal chain from cannabis use to immune disruption to psychosis vulnerability has not been demonstrated in prospective human studies. The review acknowledges significant uncertainty about central nervous system immune effects.
Questions This Raises
- ?Can immune biomarkers identify cannabis users at risk for psychosis before symptoms appear?
- ?Would anti-inflammatory interventions prevent cannabis-associated psychosis?
- ?Does the Th1-to-Th2 shift explain the specific symptom profile of cannabis-associated psychosis?
Trust & Context
- Key Stat:
- 122 studies: external cannabinoids suppress immunity while endocannabinoids enhance it
- Evidence Grade:
- This is a systematic review synthesizing a large body of basic science evidence. The proposed mechanism linking immune effects to psychosis remains theoretical.
- Study Age:
- Published in 2014. The neuroimmune hypothesis of psychosis and its relationship to cannabis has been further developed since.
- Original Title:
- Immune system: a possible nexus between cannabinoids and psychosis.
- Published In:
- Brain, behavior, and immunity, 40, 269-82 (2014)
- Authors:
- Suárez-Pinilla, Paula(2), López-Gil, José, Crespo-Facorro, Benedicto(6)
- Database ID:
- RTHC-00871
Evidence Hierarchy
Analyzes all available research on a topic using a structured method.
What do these levels mean? →Frequently Asked Questions
What is the Th1/Th2 immune shift?
The immune system balances between Th1 responses (fighting infections and tumors) and Th2 responses (fighting parasites, associated with allergies). Cannabinoids shift this balance toward Th2, which could impair the brain's ability to manage neuroinflammation.
Why is adolescence a vulnerable period?
The immune system and brain are both undergoing significant development during adolescence. Disrupting immune function during this critical window could create lasting changes in how the brain manages inflammation, potentially setting the stage for psychotic disorders in susceptible individuals.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-00871APA
Suárez-Pinilla, Paula; López-Gil, José; Crespo-Facorro, Benedicto. (2014). Immune system: a possible nexus between cannabinoids and psychosis.. Brain, behavior, and immunity, 40, 269-82. https://doi.org/10.1016/j.bbi.2014.01.018
MLA
Suárez-Pinilla, Paula, et al. "Immune system: a possible nexus between cannabinoids and psychosis.." Brain, 2014. https://doi.org/10.1016/j.bbi.2014.01.018
RethinkTHC
RethinkTHC Research Database. "Immune system: a possible nexus between cannabinoids and psy..." RTHC-00871. Retrieved from https://rethinkthc.com/research/suarez-pinilla-2014-immune-system-a-possible
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.